![](/img/cover-not-exists.png)
PMH9 A PROBABILISTIC COST-EFFECTIVENESS ANALYSIS OF ESCITALOPRAM, GENERIC CITALOPRAM AND VENLAFAXINE AS A FIRST-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN THE UNITED KINGDOM
ME Hemels, I Toumi, AG WadeVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)66079-2
File:
PDF, 66 KB
english, 2004